{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:09:42Z","timestamp":1793232582774,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100013434","name":"Center for Drug Use and HIV Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-024-01116-5","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:38:09Z","timestamp":1731591489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities"],"prefix":"10.1186","volume":"21","author":[{"given":"Joy D.","family":"Scheidell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Chueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Ciraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Hervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Dakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthoni","family":"Mahachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex S.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luther C.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"issue":"2","key":"1116_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/AOG.0000000000003666","volume":"135","author":"LK MacAfee","year":"2020","unstructured":"MacAfee LK, Harfmann RF, Cannon LM, et al. Sexual and Reproductive Health characteristics of women in Substance Use Treatment in Michigan. Obstet Gynecol. 2020;135(2):361\u20139.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1116_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/ADM.0000000000000175","volume":"10","author":"M Terplan","year":"2016","unstructured":"Terplan M, Lawental M, Connah MB, Martin CE. Reproductive Health needs among Substance Use Disorder Treatment clients. J Addict Med. 2016;10(1):20\u20135.","journal-title":"J Addict Med"},{"issue":"12","key":"1116_CR3","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1111\/jan.12442","volume":"70","author":"NL Edelman","year":"2014","unstructured":"Edelman NL, Patel H, Glasper A, Bogen-Johnston L. Sexual health risks and health-seeking behaviours among substance-misusing women. J Adv Nurs. 2014;70(12):2861\u201370.","journal-title":"J Adv Nurs"},{"key":"1116_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.drugalcdep.2016.10.027","volume":"169","author":"DJ Feaster","year":"2016","unstructured":"Feaster DJ, Parish CL, Gooden L, et al. Substance use and STI acquisition: secondary analysis from the AWARE study. Drug Alcohol Depend. 2016;169:171\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"1116_CR5","doi-asserted-by":"publisher","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","volume":"126","author":"KA Brookmeyer","year":"2019","unstructured":"Brookmeyer KA, Haderxhanaj LT, Hogben M, Leichliter J. Sexual risk behaviors and STDs among persons who inject drugs: a national study. Prev Med. 2019;126:105779.","journal-title":"Prev Med"},{"issue":"6","key":"1116_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.15585\/mmwr.mm6806a4","volume":"68","author":"SE Kidd","year":"2019","unstructured":"Kidd SE, Grey JA, Torrone EA, Weinstock HS. Increased methamphetamine, Injection Drug, and Heroin Use among women and Heterosexual men with primary and secondary Syphilis - United States, 2013\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68(6):144\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"1116_CR7","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10508-020-01684-0","volume":"49","author":"M Felsher","year":"2020","unstructured":"Felsher M, Ziegler E, Smith LR, et al. An exploration of pre-exposure Prophylaxis (PrEP) initiation among women who inject drugs. Arch Sex Behav. 2020;49(6):2205\u201312.","journal-title":"Arch Sex Behav"},{"key":"1116_CR8","doi-asserted-by":"publisher","first-page":"174550652110705","DOI":"10.1177\/17455065211070543","volume":"18","author":"B Gibson","year":"2022","unstructured":"Gibson B, Hoff E, Haas A, et al. Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders. Womens Health (Lond). 2022;18:17455065211070543.","journal-title":"Womens Health (Lond)"},{"issue":"4","key":"1116_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1086\/318131","volume":"31","author":"LY Hwang","year":"2000","unstructured":"Hwang LY, Ross MW, Zack C, Bull L, Rickman K, Holleman M. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis. 2000;31(4):920\u20136.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1116_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3109\/14659891.2016.1144805","volume":"22","author":"AB Acheampong","year":"2017","unstructured":"Acheampong AB, Striley CW, Cottler LB. Prescription opioid use, illicit drug use, and sexually transmitted infections among participants from a community engagement program in North Central Florida. J Subst Use. 2017;22(1):90\u20135.","journal-title":"J Subst Use"},{"key":"1116_CR11","unstructured":"Kaiser Family Foundation. Substance use and risky sexual activity. 2002. https:\/\/www.kff.org\/wp-content\/uploads\/2002\/01\/3214.pdf (accessed March 2022)."},{"issue":"7","key":"1116_CR12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/OLQ.0000000000001341","volume":"48","author":"SA Strathdee","year":"2021","unstructured":"Strathdee SA, Bristow CC, Gaines T, Shoptaw S. Collateral damage: a narrative review on epidemics of Substance Use disorders and their relationships to sexually transmitted infections in the United States. Sex Transm Dis. 2021;48(7):466\u201373.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"1116_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s10461-012-0276-0","volume":"17","author":"MR Khan","year":"2013","unstructured":"Khan MR, Berger A, Hemberg J, O\u2019Neill A, Dyer TP, Smyrk K. Non-injection and injection drug use and STI\/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users. AIDS Behav. 2013;17(3):1185\u201394.","journal-title":"AIDS Behav"},{"key":"1116_CR14","unstructured":"Minnesota Department of Health. Sexually transmitted and injection drug-related infections rose in Minnesota in 2016. 2017. https:\/\/www.health.state.mn.us\/news\/pressrel\/2017\/std042017.html (accessed March 2022)."},{"key":"1116_CR15","unstructured":"California Healthline. Two Crises In One: As Drug Use Rises, So Does Syphilis. 2019. https:\/\/californiahealthline.org\/news\/record-high-syphilis-rates-linked-to-drug-use\/ (accessed March 2022)."},{"key":"1116_CR16","unstructured":"Forum AP. March. Is our addiction crisis fueling the all-time high in reported STD cases? 2020. https:\/\/www.addictionpolicy.org\/post\/is-our-addiction-crisis-fueling-the-all-time-high-in-reported-std-cases (accessed 2022)."},{"issue":"9","key":"1116_CR17","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1360-0443.2008.02465.x","volume":"104","author":"DC Des Jarlais","year":"2009","unstructured":"Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104(9):1441\u20136.","journal-title":"Addiction"},{"issue":"48","key":"1116_CR18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and rural areas - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"45","key":"1116_CR19","first-page":"1488","volume":"59","author":"V Guardino","year":"2010","unstructured":"Guardino V, Des Jarlais DC, Arasteh K, et al. Syringe exchange programs - United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59(45):1488\u201391.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1116_CR20","unstructured":"NYC Health. Syringe service programs in New York City, 2019."},{"key":"1116_CR21","doi-asserted-by":"publisher","first-page":"109323","DOI":"10.1016\/j.drugalcdep.2022.109323","volume":"232","author":"CN Behrends","year":"2022","unstructured":"Behrends CN, Lu X, Corry GJ, et al. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug Alcohol Depend. 2022;232:109323.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1116_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12954-020-00395-y","volume":"17","author":"L Owens","year":"2020","unstructured":"Owens L, Gilmore K, Terplan M, Prager S, Micks E. Providing reproductive health services for women who inject drugs: a pilot program. Harm Reduct J. 2020;17(1):47.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1116_CR23","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","volume":"86","author":"AM Roth","year":"2021","unstructured":"Roth AM, Tran NK, Felsher M, et al. Integrating HIV Preexposure Prophylaxis with Community-based syringe services for women who inject drugs: results from the project SHE demonstration study. J Acquir Immune Defic Syndr. 2021;86(3):e61\u201370.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1116_CR24","unstructured":"Wilberg M. The US must tackle racial disparities among people who inject drugs and expand syringe service programmes. 2022. https:\/\/www.aidsmap.com\/news\/jan-2022\/us-must-tackle-racial-disparities-among-people-who-inject-drugs-and-expand-syringe (accessed November 2023)."},{"issue":"42","key":"1116_CR25","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.15585\/mmwr.mm7042a1","volume":"70","author":"S Handanagic","year":"2021","unstructured":"Handanagic S, Finlayson T, Burnett JC, Broz D, Wejnert C, National HIVBSSG. HIV infection and HIV-Associated behaviors among persons who inject drugs \u2013\u200923 Metropolitan Statistical areas, United States, 2018. MMWR Morb Mortal Wkly Rep. 2021;70(42):1459\u201365.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1116_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12954-023-00868-w","volume":"20","author":"K Salow","year":"2023","unstructured":"Salow K, Jack HE, Tinsley J, et al. Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys. Harm Reduct J. 2023;20(1):133.","journal-title":"Harm Reduct J"},{"issue":"14","key":"1116_CR27","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1080\/10826084.2020.1800741","volume":"55","author":"KE Lancaster","year":"2020","unstructured":"Lancaster KE, Cooper HLF, Browning CR, Malvestutto CD, Bridges JFP, Young AM. Syringe Service Program utilization, barriers, and preferences for design in rural Appalachia: differences between men and women who inject drugs. Subst Use Misuse. 2020;55(14):2268\u201377.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"1116_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12954-019-0280-z","volume":"16","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Kravietz A, Bartholomew TS, Forrest D, Tookes HE. Baseline differences in characteristics and risk behaviors among people who inject drugs by syringe exchange program modality: an analysis of the Miami IDEA syringe exchange. Harm Reduct J. 2019;16(1):7.","journal-title":"Harm Reduct J"},{"key":"1116_CR29","doi-asserted-by":"publisher","first-page":"108721","DOI":"10.1016\/j.drugalcdep.2021.108721","volume":"223","author":"L Elliott","year":"2021","unstructured":"Elliott L, Crasta D, Khan M, et al. Validation of the opioid overdose risk behavior scale, version 2 (ORBS-2). Drug Alcohol Depend. 2021;223:108721.","journal-title":"Drug Alcohol Depend"},{"key":"1116_CR30","doi-asserted-by":"crossref","unstructured":"Scheidell JD, Elliott LC, Bennett AS et al. Evaluation of self-directed specimen collection for chlamydia and gonorrhea testing among people who use drugs. Int J STD AIDS 2023: 9564624231215859.","DOI":"10.1177\/09564624231215859"},{"issue":"1","key":"1116_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1176\/appi.ajp.2012.12071000","volume":"170","author":"WE Narrow","year":"2013","unstructured":"Narrow WE, Clarke DE, Kuramoto SJ, et al. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry. 2013;170(1):71\u201382.","journal-title":"Am J Psychiatry"},{"key":"1116_CR32","unstructured":"NYC Health, Risk HIV, Prevalence among People who Inject Drugs in New York City. March and : Findings from the 2018 National HIV Behavioral Surveillance Study. https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/dires\/hiv-risk-and-prevalence-among-people-who-inject-drugs-in-nyc.pdf (accessed 2024)."},{"key":"1116_CR33","doi-asserted-by":"publisher","first-page":"108344","DOI":"10.1016\/j.jsat.2021.108344","volume":"127","author":"TS Bartholomew","year":"2021","unstructured":"Bartholomew TS, Feaster DJ, Patel H, Forrest DW, Tookes HE. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida. J Subst Abuse Treat. 2021;127:108344.","journal-title":"J Subst Abuse Treat"},{"key":"1116_CR34","unstructured":"Gibson B, See K, Vargas Estrella B, Rivera S. OnPointNYC: A baseline report on the operation of the first recognized overdose prevention centers in the United States, 2023."},{"key":"1116_CR35","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.drugalcdep.2021.108588","volume":"221","author":"MS Schuler","year":"2021","unstructured":"Schuler MS, Schell TL, Wong EC. Racial\/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999\u20132018. Drug Alcohol Depend. 2021;221:108588.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1116_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","volume":"76","author":"H Bradley","year":"2023","unstructured":"Bradley H, Hall EW, Asher A, et al. Estimated number of people who inject drugs in the United States. Clin Infect Dis. 2023;76(1):96\u2013102.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1116_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/OLQ.0b013e318186dee3","volume":"36","author":"D Huo","year":"2009","unstructured":"Huo D, Ouellet LJ. Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois. Sex Transm Dis. 2009;36(1):35\u201340.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"1116_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.drugpo.2012.03.006","volume":"23","author":"E Hyshka","year":"2012","unstructured":"Hyshka E, Strathdee S, Wood E, Kerr T. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 2012;23(4):261\u201370.","journal-title":"Int J Drug Policy"},{"issue":"5 Suppl 1","key":"1116_CR39","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/j.amepre.2021.05.044","volume":"61","author":"D Broz","year":"2021","unstructured":"Broz D, Carnes N, Chapin-Bardales J, et al. Syringe Services Programs\u2019 role in ending the HIV Epidemic in the U.S.: why we cannot do it without them. Am J Prev Med. 2021;61(5 Suppl 1):S118\u201329.","journal-title":"Am J Prev Med"},{"issue":"11","key":"1116_CR40","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/OLQ.0000000000000516","volume":"43","author":"AM Roth","year":"2016","unstructured":"Roth AM, Goldshear JL, Martinez-Donate AP, Welles S, Chavis M, Van Der Pol B. Reducing missed opportunities: pairing sexually transmitted infection screening with Syringe Exchange services. Sex Transm Dis. 2016;43(11):706\u20138.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"1116_CR41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/ADM.0000000000000508","volume":"13","author":"M Tschann","year":"2019","unstructured":"Tschann M, Wright T, Lusk H, Giorgio W, Colon A, Kaneshiro B. Understanding the Family Planning needs of female participants in a Syringe Exchange Program: a needs Assessment and Pilot Project. J Addict Med. 2019;13(5):366\u201371.","journal-title":"J Addict Med"},{"issue":"6","key":"1116_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/14659891.2021.1967486","volume":"27","author":"DJ Franz","year":"2022","unstructured":"Franz DJ, Cioffi CC. Client characteristics Associated with Desire for additional services at Syringe Exchange Programs. J Subst Use. 2022;27(6):604\u201310.","journal-title":"J Subst Use"},{"issue":"1","key":"1116_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/2632077020973362","volume":"2","author":"CC Cioffi","year":"2021","unstructured":"Cioffi CC, Seeley JR. Voluntary pregnancy screening at Syringe exchanges: a feasibility study. J Prev Health Promot. 2021;2(1):57\u201380.","journal-title":"J Prev Health Promot"},{"key":"1116_CR44","unstructured":"Centers for Disease Control and Prevention. Summary of Information on The Safety and Effectiveness of Syringe Services Programs (SSPs). 2023. https:\/\/www.cdc.gov\/ssp\/syringe-services-programs-summary.html (accessed January 2024)."},{"key":"1116_CR45","unstructured":"Legislative Analysis and Public Policy Association. Syringe Service Programs: Summary of State Laws, 2023."},{"key":"1116_CR46","unstructured":"Land E. We say needle exchange, but open access\u2014not one-for-one exchange\u2014is best for health. 2018. https:\/\/www.sfaf.org\/collections\/beta\/we-say-needle-exchange-but-open-access-not-one-for-one-exchange-is-best-for-health\/ (accessed January 2024)."},{"issue":"1","key":"1116_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/07853890.2021.2022188","volume":"54","author":"SM Grieb","year":"2022","unstructured":"Grieb SM, Harris R, Rosecrans A, et al. Awareness, perception and utilization of a mobile health clinic by people who use drugs. Ann Med. 2022;54(1):138\u201349.","journal-title":"Ann Med"},{"issue":"3","key":"1116_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/dar.13797","volume":"43","author":"J Woolley","year":"2024","unstructured":"Woolley J, Savic M, Garfield JBB, et al. Experiences of telehealth among people receiving alcohol and other drug treatment during the COVID-19 pandemic: implications for future telehealth delivery. Drug Alcohol Rev. 2024;43(3):694\u2013704.","journal-title":"Drug Alcohol Rev"},{"issue":"9","key":"1116_CR49","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/10826084.2023.2212279","volume":"58","author":"DR Fine","year":"2023","unstructured":"Fine DR, Joyce A, Chang Y, et al. Health Care utilization among homeless-experienced adults who were seen by a Mobile Addiction Health Clinic in Boston, Massachusetts: a quasi-experimental study. Subst Use Misuse. 2023;58(9):1115\u201320.","journal-title":"Subst Use Misuse"},{"issue":"7","key":"1116_CR50","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/add.16486","volume":"119","author":"KR Page","year":"2024","unstructured":"Page KR, Weir BW, Zook K, et al. Integrated care van delivery of evidence-based services for people who inject drugs: a cluster-randomized trial. Addiction. 2024;119(7):1276\u201388.","journal-title":"Addiction"},{"issue":"1","key":"1116_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13722-023-00427-5","volume":"18","author":"RE Stewart","year":"2023","unstructured":"Stewart RE, Christian HP, Cardamone NC, et al. Mobile service delivery in response to the opioid epidemic in Philadelphia. Addict Sci Clin Pract. 2023;18(1):71.","journal-title":"Addict Sci Clin Pract"},{"key":"1116_CR52","doi-asserted-by":"publisher","first-page":"108828","DOI":"10.1016\/j.jsat.2022.108828","volume":"140","author":"MM Paschen-Wolff","year":"2022","unstructured":"Paschen-Wolff MM, Velasquez R, Aydinoglo N, Campbell ANC. Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States. J Subst Abuse Treat. 2022;140:108828.","journal-title":"J Subst Abuse Treat"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01116-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T14:05:28Z","timestamp":1731593128000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01116-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01116-5","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}